These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 7299243

  • 21. New insights into uremic toxicity.
    Raff AC, Meyer TW, Hostetter TH.
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):560-5. PubMed ID: 18941347
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of glyoxal and methylglyoxal levels in uremic patients under peritoneal dialysis.
    Lapolla A, Flamini R, Lupo A, Aricò NC, Rugiu C, Reitano R, Tubaro M, Ragazzi E, Seraglia R, Traldi P.
    Ann N Y Acad Sci; 2005 Jun; 1043():217-24. PubMed ID: 16037242
    [Abstract] [Full Text] [Related]

  • 23. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D.
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [Abstract] [Full Text] [Related]

  • 24. An oral load of the early glycation compound lactuloselysine fails to accumulate in the serum of uraemic patients.
    Schwenger V, Morath C, Schönfelder K, Klein W, Weigel K, Deppisch R, Henle T, Ritz E, Zeier M.
    Nephrol Dial Transplant; 2006 Feb; 21(2):383-8. PubMed ID: 16204288
    [Abstract] [Full Text] [Related]

  • 25. Protein binding of diazepam and digitoxin in uremic and normal serum.
    Kober A, Sjöholm I, Borgå O, Odar-Cederlöf I.
    Biochem Pharmacol; 1979 Apr 01; 28(7):1037-42. PubMed ID: 444260
    [No Abstract] [Full Text] [Related]

  • 26. Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.
    Nishio T, Takamura N, Nishii R, Tokunaga J, Yoshimoto M, Kawai K.
    Nephrol Dial Transplant; 2008 Jul 01; 23(7):2304-10. PubMed ID: 18390890
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics of low dose sulfadiazine in patients with renal failure.
    Seppänen J, Viranta M, Julkunen R, Wilén G.
    Ann Clin Res; 1980 Jul 01; (25):31-7. PubMed ID: 7377747
    [Abstract] [Full Text] [Related]

  • 28. Correction of drug binding defects in uremia in vitro by anion exchange resin treatment.
    Lichtenwalner DM, Suh B, Lorber B, Rudnick MR, Craig WA.
    Biochem Pharmacol; 1982 Nov 01; 31(21):3483-7. PubMed ID: 7150368
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Uremic toxins].
    Vanholder R.
    Nephrologie; 2003 Nov 01; 24(7):373-6. PubMed ID: 14650749
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM, Moore P, Quon CY.
    Res Commun Mol Pathol Pharmacol; 1995 Apr 01; 88(1):51-62. PubMed ID: 7620838
    [Abstract] [Full Text] [Related]

  • 35. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A, Nishiura T, Ishino M, Yamamoto Y, Ogita I, Kiso Y, Takada K.
    Biopharm Drug Dispos; 1996 Dec 01; 17(9):739-51. PubMed ID: 8968527
    [Abstract] [Full Text] [Related]

  • 36. Interaction of valproic acid with nonsteroidal antiinflammatory drugs mefenamic acid and fenoprofen in normal and uremic sera: lack of interaction in uremic sera due to the presence of endogenous factors.
    Dasgupta A, Emerson L.
    Ther Drug Monit; 1996 Dec 01; 18(6):654-9. PubMed ID: 8946661
    [Abstract] [Full Text] [Related]

  • 37. Fast atom bombardment mass spectrometric determination of the molecular weight range of uremic compounds that displace phenytoin from protein binding: absence of midmolecular uremic toxins.
    Dasgupta A, Malik S.
    Am J Nephrol; 1994 Dec 01; 14(3):162-8. PubMed ID: 7977474
    [Abstract] [Full Text] [Related]

  • 38. Plasma protein aspartyl damage is increased in hemodialysis patients: studies on causes and consequences.
    Perna AF, Ingrosso D, Satta E, Lombardi C, Galletti P, D'Aniello A, De Santo NG.
    J Am Soc Nephrol; 2004 Oct 01; 15(10):2747-54. PubMed ID: 15466280
    [Abstract] [Full Text] [Related]

  • 39. The role of tryptophan, 5-hydroxy indole-3-acetic acid and their protein binding in uremic patients.
    Qureshi GA, Baig SM.
    Biochem Mol Biol Int; 1993 Mar 01; 29(3):411-9. PubMed ID: 7683549
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.